NMDA channel regulation by channel-associated protein tyrosine kinase Src

Science

Volumn 275, Issue 5300, 1997, Pages 674-678

  Yu, Xian Min ^a   Askalan, Rand ^a   Keil II, Gary J ^a   Salter, Michael W ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

N METHYL DEXTRO ASPARTIC ACID; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHANNEL GATING; ENZYME ACTIVITY; ENZYME REGULATION; NERVE CELL PLASTICITY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYNAPTIC TRANSMISSION;

AMINO ACID SEQUENCE; ANIMALS; CELLS, CULTURED; ION CHANNEL GATING; ION CHANNELS; MOLECULAR SEQUENCE DATA; N-METHYLASPARTATE; NEURONS; OLIGOPEPTIDES; PATCH-CLAMP TECHNIQUES; PHOSPHORYLATION; PHOSPHOTYROSINE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SRC-FAMILY KINASES; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 0031053363     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.275.5300.674     Document Type: Article

References (37)

1. C. J. McBain and M. L. Mayer, Physiol. Rev. 74, 723 (1994); M. Hollmann and S. Heinemann, Annu. Rev. Neurosci. 17, 31 (1994).
2. C. J. McBain and M. L. Mayer, Physiol. Rev. 74, 723 (1994); M. Hollmann and S. Heinemann, Annu. Rev. Neurosci. 17, 31 (1994).
3. L. A. Raymond, C. D. Blackstone, R. L. Huganir, Trends Neurosci. 16, 147 (1993).
4. Y. T. Wang and M. W. Salter, Nature 369, 233 (1994); G. Köhr and P. H. Seeburg, J. Physiol. (London) 492, 445 (1996).
5. Y. T. Wang and M. W. Salter, Nature 369, 233 (1994); G. Köhr and P. H. Seeburg, J. Physiol. (London) 492, 445 (1996).
6. Y. T. Wang, X.-M. Yu, M. W. Salter, Proc. Natl. Acad. Sci. U.S.A. 93, 1721 (1996).
7. L. Chen and L.-Y. M. Huang, Nature 356, 521 (1992); S. R. Kelso, T. E. Nelson, J. P. Leonard, J. Physiol. (London) 449, 705 (1992); G. M. Durand et al., Proc. Natl. Acad. Sci. U.S.A. 89, 9359 (1992).
8. L. Chen and L.-Y. M. Huang, Nature 356, 521 (1992); S. R. Kelso, T. E. Nelson, J. P. Leonard, J. Physiol. (London) 449, 705 (1992); G. M. Durand et al., Proc. Natl. Acad. Sci. U.S.A. 89, 9359 (1992).
9. L. Chen and L.-Y. M. Huang, Nature 356, 521 (1992); S. R. Kelso, T. E. Nelson, J. P. Leonard, J. Physiol. (London) 449, 705 (1992); G. M. Durand et al., Proc. Natl. Acad. Sci. U.S.A. 89, 9359 (1992).
10. H. Thoenen, Science 270, 593 (1995); S. O. Meakin and E. M. Shooter, Trends Neurosci. 15, 323 (1992).
11. H. Thoenen, Science 270, 593 (1995); S. O. Meakin and E. M. Shooter, Trends Neurosci. 15, 323 (1992).
12. J. S. Brugge et al., Nature 316, 554 (1985); R. Martinez, B, Mathey-Prevot, A. Bernards, D. Baltimore, Science 237, 411 (1987).
13. J. S. Brugge et al., Nature 316, 554 (1985); R. Martinez, B, Mathey-Prevot, A. Bernards, D. Baltimore, Science 237, 411 (1987).
14. c-src: Upstate Biotechnology; anti-cst1, anti-src1, and Src(40-58): S. Courtneidge, SUGEN, Redwood City, CA; and BAPTA: Molecular Probes. All other chemicals were from Sigma. Abbreviations for the amino acid residues are as follows: A, Ala; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; P, Pro; Q, Gln; R, Arg; S, Ser; V, Val; and Y, Tyr.
15. X. Liu et al., Oncogene 8, 1119 (1993). A concentration of 1 mM was the minimum required to increase Src activity; at concentrations of ≤0.1 mM the peptide had no effect.
16. c (mean ± SEM) for the bursts, clusters, and superclusters were 3.3 ± 0.4, 50.7 ± 8.0, and 500 ± 130 ms, respectively. Synaptic Toolbench software (Y. DeKoninck, McGill University) was used to analyze the bursts, clusters, and superclusters.
17. c (mean ± SEM) for the bursts, clusters, and superclusters were 3.3 ± 0.4, 50.7 ± 8.0, and 500 ± 130 ms, respectively. Synaptic Toolbench software (Y. DeKoninck, McGill University) was used to analyze the bursts, clusters, and superclusters.
18. c (mean ± SEM) for the bursts, clusters, and superclusters were 3.3 ± 0.4, 50.7 ± 8.0, and 500 ± 130 ms, respectively. Synaptic Toolbench software (Y. DeKoninck, McGill University) was used to analyze the bursts, clusters, and superclusters.
19. X.-M.Yu, R. Askalan, G. J. Keil II, M. W. Salter, data not shown.
20. S. Roche, M. Koegl, M. V. Barone, M. F. Roussel, S. A. Courtneidge, Mol. Cell. Biol. 15, 1102 (1995).
21. S. Roche, S. Fumagalli, S. A. Courtneidge, Science 269, 1567 (1995).
22. Spinal cord membranes were prepared from fetal rats (E17 to E19) with methods adapted from Sheng et al. [M. Sheng, M.-L. Tsaur, Y. N. Jan, L. Y. Jan, Neuron 9, 271 (1992)]. Membrane proteins were solubilized under nondenaturing or denaturing conditions. Nondenaturing conditions: ice-cold 50 mM tris-HCI(pH 7.6) containing 15O mM NaCI, 1% igepal ca630 0.5% sodium deoxycholate, 0.1% SDS, 2 mM EDTA, 1 mM sodium orthovanadate, and the protease inhibitors pepstatin A (20 μg/ml), leupeptin (20 μg/ml), aprotinin (20 μg/ml), and phenylmethylsulfonyl flouride (1 mM). Denaturing conditions: boiling in 1 % SDS followed by fivefold dilution with 50 mM tris-HCI (pH 7.6) containing 190 mM NaCl, 1.25% Triton X-100, 1 mM sodium orthovanadate, 6 mM EDTA, and the protease inhibitors listed above. Solubilized proteins (300 μg) were centrifuged at 14,000g to remove insoluble material and then incubated with anti-NR1 (5 μg) or anti-Src (1:100 dilution) or with control, nonspecific IgG (5 μg) overnight at 4°C. Immune complexes were isolated by the addition of 50 μl of protein G-Sepharose beads followed by incubation for 4 hours at 4°C. Immunoprecipitates were then washed five times with lysis buffer, resuspended in 2 × Laemmli sample buffer, and boiled for 5 min. The samples were subjected to SDS-polyacrylamide gel electrophoresis (PAGE) (10% gel) and transferred to a nitrocellulose membrane. Analysis was performed by repeated stripping of the membrane and successive probing with anti-NR1 (5 μg), anti-Src (1:500 dilution), or anti-Kv3.1 (1:4000 dilution). Sources of antibodies: anti-NR1 (mouse monoclonal anti-NMDAR1): Pharmingen; anti-Src (monoclonal antibody 327): J. Bolen, DNAX, Palo Alto, CA; nonspecific mouse IgG, Calbiochem, San Diego, CA; and anti-Kv3.1 (rabbit antisera): T. Perney, Rutgers University.
23. M. Sheng, J. Cummings, L. A. Roldan, Y. N. Jan, L. Y. Jan, Nature 368, 144 (1994).
24. T. M. Perney and L. K. Kaczmarek, Semin. Neurosci. 5, 135 (1993).
25. 2, 11 mM EGTA, 10 mM Hepes, and 4 mM MgATP (pH 7.25, 285 to 305 mosM). EPQ(pY)-EEIPIA, EPQYEEIPIA, anti-src1, Src(40-58), or sSrc(40-58) were added to the intracellular solution as required. Whole-cell currents were recorded with an AxoPatch 1D amplifier (Axon Instruments) that were digitized (33 KHz) and stored on videotape. Detection and analysis of mEPSCs was done off-line (Synaptic Toolbench) after alignment of their rising edges. Mean mEPSCs contained at least 30 traces. Traces with more than one mEPSC per 200-ms recording period, typically 1 to 5% of the total, were not included in the analysis. Under the present recording conditions, spontaneously occurring mEPSCs were observed in most cells. In all cells, the frequency of the mEPSCs was facilitated by the local application of hypertonic sucrose solution. The slower component of the mEPSCs was blocked by D,L-2-amino-5-phosphonovaleric acid and the fast component was abolished by 6,7-dinitroquinoxaline-2,3(1H,4H)-dione (DNQX, 10 μM).
26. J. M. Bekkers and C. F. Stevens, Nature 341, 230 (1989).
27. S. G. N. Grant et al., Science 258, 1903 (1992); P. Soriano, C. Montgomery, R. Geske, A, Bradley, Cell 64, 693 (1991).
28. S. G. N. Grant et al., Science 258, 1903 (1992); P. Soriano, C. Montgomery, R. Geske, A, Bradley, Cell 64, 693 (1991).
29. I. S. Moon, M. L. Apperson, M. B. Kennedy, Proc. Natl. Acad. Sci. U.S.A. 91, 3954 (1994); L. F. Lau and R. L. Huganir, J. Biol. Chem. 270, 20036 (1995).
30. I. S. Moon, M. L. Apperson, M. B. Kennedy, Proc. Natl. Acad. Sci. U.S.A. 91, 3954 (1994); L. F. Lau and R. L. Huganir, J. Biol. Chem. 270, 20036 (1995).
31. H.-C. Kornau, L. T. Schenker, M. B. Kennedy, P. H. Seeburg, Science 269, 1737 (1995); M. D. Ehlers, S. Zhang, J. P. Bernhardt, R. L. Huganir, Cell 84, 745 (1996).
32. H.-C. Kornau, L. T. Schenker, M. B. Kennedy, P. H. Seeburg, Science 269, 1737 (1995); M. D. Ehlers, S. Zhang, J. P. Bernhardt, R. L. Huganir, Cell 84, 745 (1996).
33. B. Edmonds and D. Colquhoun, Annu. Rev. Physiol. 5, 495 (1995).
34. D. Lieberman and I. Mody, Nature 369, 235 (1994).
35. A. R. Boxall, B. Lancaster, J. Garthwaite, Neuron 16, 805 (1996).
36. G. Superti-Furga and S. A. Courtneidge, Bioessays 17, 321 (1995).
37. We thank S. Courtneidge, J. Bolen, T. Perney, and R. Wenthold for antibodies; J. F. MacDonald, T. Pawson, and J. C. Roder for critical comments on the manuscript; and Y. De Koninck for software used in analysis. Supported by a grant from the Medical Research Council (MRC) of Canada (M.W.S.) and by the Nicole Fealdman Memorial Fund. M.W.S. is an MRC Scholar, X.-M.Y. is supported by a Fellowship from the Spinal Cord Research Foundation of the Paralyzed Veterans of America, and R.A. is a Fellow of the Rick Hansen Man in Motion Foundation. We thank J. L. Hicks for preparing and maintaining cell cultures and for technical assistance.